Correction to: Evaluation of EpCAM-specific exosomal lncRNAs as potential diagnostic biomarkers for lung cancer using droplet digital PCR

Correction to: Journal of Molecular Medicine (2022) 100:87–100 https://doi.org/10.1007/s00109-021-02145-4

In Fig. 2c, the two pictures in the red boxes were pasted in the wrong place. Their positions should be swapped. Now, they were switched.

Fig. 2

The effect of EpCAM-specific exosomes on lung cancer. The total exosomes from healthy people; the EpCAM-specific exosomes from NSCLC patients without (M0)/with (M1) metastasis were isolated and resuspended in cell culture medium and further cocultured with Beas-2B and NCI-H1299 cells. The EpCAM-specific exosomes from M0 and M1 patients promote cell proliferation, cell migration, and invasion in Beas-2B (a, c, e) and NCI-H1299 cells (b, d, f). The western blot shows that the levels of E-cadherin are much lower, and the levels of N-cadherin and Vimentin proteins are higher in Beas-2B (g) and NCI-H1299 (h) cells cocultured with EpCAM-specific exosomes from M0 and M1 patients than those cocultured with total exosomes from healthy people. i NCI-H1299 cells were injected subcutaneously into the nude mouse to generate lung tumor, and then, total exosomes and EpCAM-specific exosomes were injected twice into lung tumors. (j, k, l, m) The tumor sizes were bigger in the mice injected with EpCAM-specific exosomes from M0 and M1 patients than those injected with total exosomes from healthy people

The original article has been corrected.